Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for Asleep–Awake–Asleep awake craniotomy anesthesia
jRCT1041200094Recruiting
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in brain neoplasm (2 arms). Primary endpoint: Time to awakening before awake phase. Started Feb 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on jRCT1041200094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041200094.